Spanish Red Biotech Pipeline
< Back
Drugs: Multinational Subsidiaries
Home
Toggle navigation
Pipeline
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
RESEARCH PLATFORMS
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Search
Charts
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Green pipeline
White pipeline
Spanish Red Biotech Pipeline
/
Pipeline
/
Drugs: Multinational Subsidiaries
Novo Nordisk Pharma
Liraglutide 3mg
Type:
Biodrugs/ Drugs
Therapeutic area:
Metabolic / Endocrinology
Indication:
Obesity
Phase:
4
Registration
,
3
Phase III in Spain
,
2
Phase II in Spain
,
1
Phase I